Dolores Guevara

Dolores Guevara serves as Principal CEO at Farmacia Universal. Farmacia Universal operates in the pharmaceuticals sector with approximately 240.0 employees.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • Our database includes 201,469 c suite-level executives.

Route 53 Amazon SES Outlook Amazon AWS Facebook Login (Connect) Mobile Friendly reCAPTCHA Facebook Custom Audiences Google Maps WordPress.org Vimeo YouTube Ubuntu Google AdWords Conversion Hotjar Google Analytics Google Tag Manager Bootstrap Framework Apache Facebook Widget Google Maps (Non Paid Users) Gusto SAP Centro AI Canal

medicina & formulas magistrales pharmaceutical manufacturing pharmacy online shopping wellness dermocosmetics adult care baby products formulas medical devices prescription formulas delivery service healthcare personal care vitamins supplements gastrointestinal care medical supplies skin care oral care infant nutrition hygiene products diapers adult incontinence products surgery care pain relief respiratory care antibiotics antihypertensive diabetics orthopedics serums ampoules multivitamins home care elderly care professional pharmacy pharmaceutical quality custom prescriptions nutritional supplements health services customer support treatment solutions personalized medicine frequently asked questions correspondence with pharmacies payment methods special offers health care products corporate sales product categories online order tracking pharmaceuticals medical e-commerce consumer internet consumers internet information technology & services hospital & health care health care health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Dolores Guevara in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Farmacia Universal.

Dolores Guevara's Position in the MessageCEO Database

• •Dolores Guevara is 1 of 1 verified executive contact we track at Farmacia Universal.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •16 verified contacts work at pharmaceuticals companies in the 240.0 employee range (same size as Farmacia Universal).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Dolores Guevara directly?

Dolores Guevara's verified email address is available to MessageCEO Pro subscribers. They currently serve as Principal CEO at Farmacia Universal. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Dolores Guevara work for?

Dolores Guevara is Principal CEO at Farmacia Universal, a company in the pharmaceuticals sector with 240.0 employees.

Can I pitch or sell to Dolores Guevara?

As Principal CEO at Farmacia Universal, Dolores Guevara is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Dolores Guevara directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Dolores Guevara in?

Dolores Guevara works in the pharmaceuticals industry as Principal CEO at Farmacia Universal. MessageCEO provides verified contact information for executives across all major industries.

Is Dolores Guevara's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Dolores Guevara's profile is kept up-to-date with the latest available information.

Last updated: July 21, 2026